タイトル | Crystal structure of human GAC in complex with inhibitor UPGL00012 |
---|
ジャーナル・号・ページ | To Be Published |
---|
掲載日 | 2019年10月3日 (構造データの登録日) |
---|
著者 | Huang, Q. / Cerione, R.A. |
---|
リンク | PubMedで検索 |
---|
手法 | X線回折 |
---|
解像度 | 2.5 - 3 Å |
---|
構造データ | PDB-6ujg: Crystal structure of human GAC in complex with inhibitor UPGL00012 手法: X-RAY DIFFRACTION / 解像度: 3 Å PDB-6ul9: Crystal structure of human GAC in complex with inhibitor UPGL00023 手法: X-RAY DIFFRACTION / 解像度: 2.5 Å PDB-6umc: Crystal structure of human GAC in complex with inhibitor UPGL00012 手法: X-RAY DIFFRACTION / 解像度: 2.75 Å PDB-6umd: Crystal structure of human GAC in complex with inhibitor UPGL00012 手法: X-RAY DIFFRACTION / 解像度: 2.7 Å PDB-6ume: Crystal structure of human GAC in complex with inhibitor UPGL00012 手法: X-RAY DIFFRACTION / 解像度: 2.9 Å PDB-6umf: Crystal structure of human GAC in complex with inhibitor UPGL00012 手法: X-RAY DIFFRACTION / 解像度: 2.68 Å |
---|
化合物 | ChemComp-Q9A: N-{5-[(3S)-3-{[5-(acetylamino)-1,3,4-thiadiazol-2-yl]amino}pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide
ChemComp-Q9M: 2-phenyl-N-{5-[(1-{5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}azetidin-3-yl)oxy]-1,3,4-thiadiazol-2-yl}acetamide
ChemComp-U27: 2-phenyl-N-{5-[(3R)-3-({5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}oxy)pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide
ChemComp-QAJ: 2-(pyridin-3-yl)-N-(5-{4-[(5-{[(pyridin-3-yl)acetyl]amino}-1,3,4-thiadiazol-2-yl)amino]piperidin-1-yl}-1,3,4-thiadiazol-2-yl)acetamide
ChemComp-QAM: N-(5-{[1-(5-amino-1,3,4-thiadiazol-2-yl)piperidin-4-yl]oxy}-1,3,4-thiadiazol-2-yl)-2-phenylacetamide
|
---|
由来 | homo sapiens (ヒト)
|
---|
キーワード | HYDROLASE/HYDROLASE INHIBITOR / Inhibitor / Complex / HYDROLASE / HYDROLASE-HYDROLASE INHIBITOR complex |
---|